NCT01495325

Brief Summary

Exposure to air pollution is a well established risk factor for the development of heart disease. Firefighters are exposed to excess air pollution in the form of wood smoke during the extinguishing of forest or woodland fires. Heart attacks in on-duty firefighters have been linked to specific duties and in particular fire suppression, but the reasons for this increase in risk are not well understood. Exposure to wood smoke may alter blood vessel function and increase blood clot formation to explain the link between fire suppression and heart attacks. The investigators wish to determine the effect of exposure to wood smoke at concentrations found at the perimeter of a woodland fire on blood vessel function and clotting in healthy non-smoking male professional firefighters or volunteers. Volunteers will be studied before and after inhalation of wood smoke or clean air for one hour in a purpose built whole-body exposure chamber. The investigators will perform comprehensive vascular assessments thereafter. Understanding the effects of wood smoke on the blood vessels and clotting will be an important first step in helping to protect firefighters from heart disease. Through research, the investigators hope to identify methods to minimise the risk of heart attacks in firefighters and understand the health effects of a major source of air pollution that is relevant to the general population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 11, 2011

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 20, 2011

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
Last Updated

June 21, 2021

Status Verified

June 1, 2021

Enrollment Period

2.9 years

First QC Date

October 11, 2011

Last Update Submit

June 17, 2021

Conditions

Keywords

FirefighterWoodsmokeVascular functionAir PollutionEndothelial functionThrombosis

Outcome Measures

Primary Outcomes (1)

  • Forearm blood flow measured by venous occlusion plethysmography in response to infused vasodilators

    4-6 hours after exposure

Secondary Outcomes (2)

  • Ex-vivo thrombus formation using the Badimon chamber

    2 hours after exposure

  • Plasma t-PA and PAI concentrations following infusion of bradykinin

    During forearm study, 4-6hours after exposure

Study Arms (2)

Filtered Air Exposure

SHAM COMPARATOR

1 hour exposure to filtered air during intermittent exercise

Procedure: Forearm Vascular StudyProcedure: Badimon Chamber

Woodsmoke Exposure

ACTIVE COMPARATOR

1 hour exposure to dilute woodsmoke at a concentration of 1000µg/m3 during intermittent exercise

Procedure: Forearm Vascular StudyProcedure: Badimon Chamber

Interventions

Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 µg/min).

Also known as: Other Names:, BK, SNP, ACh
Filtered Air ExposureWoodsmoke Exposure

Ex-vivo assessment of thrombus formation using the Badimon Chamber

Filtered Air ExposureWoodsmoke Exposure

Eligibility Criteria

Age18 Years - 35 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Non-smoking healthy male firefighters or volunteers

You may not qualify if:

  • Current smoker or regular users of snus
  • History of lung or ischaemic heart disease
  • Malignant arrhythmia
  • Systolic blood pressure \>190mmHg or \<100mmHg
  • Renal or hepatic dysfunction
  • Previous history of blood dyscrasia
  • Unable to tolerate the supine position
  • Blood donation within the last 3 months
  • Recent respiratory tract infection within the past 4 weeks
  • Routine medication including aspirin and NSAIDs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Umeå University

Umeå, Västerbotten County, SE-901 85, Sweden

Location

Related Publications (2)

  • Hunter AL, Unosson J, Bosson JA, Langrish JP, Pourazar J, Raftis JB, Miller MR, Lucking AJ, Boman C, Nystrom R, Donaldson K, Flapan AD, Shah AS, Pung L, Sadiktsis I, Masala S, Westerholm R, Sandstrom T, Blomberg A, Newby DE, Mills NL. Effect of wood smoke exposure on vascular function and thrombus formation in healthy fire fighters. Part Fibre Toxicol. 2014 Dec 9;11:62. doi: 10.1186/s12989-014-0062-4.

  • Langrish JP, Watts SJ, Hunter AJ, Shah AS, Bosson JA, Unosson J, Barath S, Lundback M, Cassee FR, Donaldson K, Sandstrom T, Blomberg A, Newby DE, Mills NL. Controlled exposures to air pollutants and risk of cardiac arrhythmia. Environ Health Perspect. 2014 Jul;122(7):747-53. doi: 10.1289/ehp.1307337. Epub 2014 Mar 25.

MeSH Terms

Conditions

Thrombosis

Condition Hierarchy (Ancestors)

Embolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Nicholas L Mills, MBChB PhD

    University of Edinburgh

    STUDY DIRECTOR
  • David E Newby, MD PhD

    University of Edinburgh

    STUDY CHAIR
  • Anders Blomberg, MD PhD

    Umeå University

    STUDY DIRECTOR
  • Thomas Sandström, MD PhD

    Umeå Univerisity

    STUDY DIRECTOR
  • Amanda L Hunter, MBChB

    University of Edinburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2011

First Posted

December 20, 2011

Study Start

September 1, 2011

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

June 21, 2021

Record last verified: 2021-06

Locations